Jane Fraser

Jane Fraser is an experienced leader in the pharmaceutical and biotechnology industries, currently serving as Chief Operating Officer at RoslinCT since March 2023. Previously, Jane held the position of Site Head at NextPharma from April 2021 to March 2023, and at Lonza from July 2017 to March 2021. Additional roles include Research and Development Director at Encap Drug Delivery for seven years, as well as significant positions at Aptuit, Quintiles, and Vitrolife, providing expertise in formulation and research. Jane Fraser's educational background includes a degree from the University of the West of Scotland, completed between 1991 and 1998.